Details for 2017728614

Up to date per 02.04.2026

Actions

Title / Product Name

POLYMORPHE VON N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOL-4-CARBOXAMID ALS KALLIKREIN INHIBITOREN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017728614

EP Publication Number

3464265

E-Number

1504227

Language

PCT Number

GB17051579

Publication Date

10.04.2019 A

13.07.2022 B1

Registration Date

13.07.2022

AT Publication Date

15.08.2022

Application Date

01.06.2017

Registration Number

Priorities

01.06.2016

201609607

01.06.2016

201662344059 P

IPC

C07D 401/10 20060101AFI20171208BHEP

Maximum Duration of Protection

01.06.2037

Owner

Kalvista Pharmaceuticals LimitedPorton Science Park Bybrook Road Porton Down Wiltshire SP4 0BFGB

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

BEATON, Haydn1 Bayliss Close Quorn Loughborough LE12 8PFGB

CROWE, David Malcolm5 Boulton Road Reading RG2 0NHGB

EDWARDS, Hannah Joyc/o Kalvista Pharmaceuticals Limited Building 227 Tetricus Science Park Porton Down Salisbury SP4 0JQGB

GRIFFITHS-HAYNES, Nicholas James24 Brookside Avenue Pailton Warwickshire CV23 0QGGB

Information about Fees